Načítá se...
Targeting protein-protein interaction interfaces in COVID-19 drug discovery
To date, the COVID-19 pandemic has claimed over 1 million human lives, infected another 50 million individuals and wreaked havoc on the global economy. The crisis has spurred the ongoing development of drugs targeting its etiological agent, the SARS-CoV-2. Targeting relevant protein-protein interact...
Uloženo v:
| Vydáno v: | Comput Struct Biotechnol J |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Research Network of Computational and Structural Biotechnology
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8064971/ https://ncbi.nlm.nih.gov/pubmed/33936565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2021.04.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|